Choosing a CMS for a pharmaceutical digital property is not a software evaluation exercise — it is an organizational decision with long-term consequences. The platform you select will shape how your content teams work, how long regulatory approvals take, how much your IT team spends on maintenance, and how quickly you can respond when a safety update requires immediate changes across 15 market sites.
This comparison covers the five platforms we most frequently encounter in pharmaceutical CMS evaluations — Magnolia (with Campus+), Adobe Experience Manager, Drupal, WordPress, and Sitecore — plus the no-CMS / custom development option. We have implemented or advised on all five in regulated environments.
At a Glance
| Capability | Magnolia / Campus+ | AEM | Drupal | WordPress | Sitecore | No CMS |
|---|---|---|---|---|---|---|
| MLR Workflow | Built-in (Campus+ templates) | Built-in (configurable) | Configurable (modules) | Plugin-dependent | Built-in (configurable) | Must be custom-built |
| Multi-site / Multi-market | Strong | Very strong (MSM) | Strong (multisite) | Limited | Strong | Manual / not scalable |
| Headless / API | Yes (REST + GraphQL) | Yes | Yes (JSON:API) | Yes (limited) | Yes (GraphQL) | Full control |
| Localization | TMS integration | TMS integration (TIF) | Core + TMS | Plugin-dependent | Built-in | Manual |
| DAM | Basic | Very strong (AEM Assets) | Via modules | Via plugins | Strong (Content Hub) | None |
| Personalization | Limited | Strong (Adobe Target) | Limited | Limited | Very strong (CDP + Personalize) | None |
| Licensing cost | Enterprise | Enterprise (highest) | Free (open source) | Free (open source) | Enterprise | None |
| Implementation complexity | High | Very high | High | Low to medium | High | Very high (custom) |
| Pharma pre-built features | Yes (Campus+) | No | No | No | No | None |
| Non-developer editing | Yes | Yes | Yes | Yes | Yes | No |
| Audit trail | Built-in | Built-in | Built-in | Limited | Built-in | Must be custom-built |
Magnolia and Campus+: The Pharma-Focused Platform
Strengths: Magnolia's content model architecture — treating content as structured data rather than pages — maps more naturally to pharmaceutical complexity than most platforms. Campus+, the enterprise distribution, ships with workflow templates, translation connectors, and multi-market governance features pre-configured for life sciences. Implementation time is faster than AEM or Sitecore for pharma use cases because you are configuring, not building.
Weaknesses: The platform is less widely known than AEM or Sitecore, which means smaller talent pools and fewer third-party integrations. Personalization capabilities are more limited than Sitecore, and the DAM is less capable than AEM Assets at very high volumes.
Best for: Mid-to-large pharma organizations that need multi-market content governance, MLR workflow, and TMS integration — and want a purpose-built solution rather than a general enterprise platform configured for pharma.
AEM: Maximum Capability, Maximum Investment
Strengths: AEM's Multi-Site Manager is the most capable multi-market management tool in the comparison. The integration with Adobe Analytics, Adobe Target, and Adobe Campaign makes AEM the strongest choice for organizations already running the Adobe stack. AEM Assets handles very high asset volumes with sophisticated rights management. The talent pool of AEM developers and architects is larger than any other enterprise CMS.
Weaknesses: AEM is the most expensive platform in this comparison on every dimension — licensing, implementation, and ongoing operations. Projects routinely exceed 18 months for full implementation. The platform requires a dedicated team to operate at enterprise scale. Organizations underestimating the operational cost create ongoing technical debt.
Best for: Large pharma with existing Adobe investments, 15+ markets to manage, complex asset operations, and budget for a multi-year platform program. Not appropriate for organizations who cannot dedicate the resources to realize its full capability.
Drupal: Open Source Flexibility for Technical Teams
Strengths: No licensing cost makes Drupal competitive on total cost of ownership, especially for pharma companies managing a large portfolio of brand sites. The access control and permission system is the most granular of any platform in this comparison — genuinely useful for complex HCP portal authentication. The decoupled architecture integrates cleanly with modern front-end stacks. No vendor lock-in: the platform and your data remain under your control.
Weaknesses: Drupal's flexibility is its complexity. Implementing pharma-appropriate workflow, content governance, and localization requires significant configuration and module integration — there are no pharma-specific templates. Every Drupal implementation is custom, which means higher implementation risk if the development team lacks regulated-industry experience.
Best for: Pharma organizations with strong internal development capacity or a trusted technical partner, who want maximum architectural flexibility and are willing to invest in configuration and ongoing platform maintenance. Strong choice for HCP portals and authenticated experiences.
WordPress: Right Tool for the Right Job
Strengths: WordPress is the fastest and cheapest path to a functioning pharmaceutical corporate or disease awareness site. Editorial teams need minimal training. The ecosystem of themes and plugins covers most standard requirements. For properties that do not carry regulatory content — investor relations, recruitment, corporate communications — it is genuinely the right tool.
Weaknesses: WordPress was not designed for MLR workflow, multi-market governance, or complex content modeling. Plugin-based solutions for these requirements carry higher technical risk and ongoing maintenance burden than purpose-built platforms. Security management across a plugin-heavy installation requires dedicated attention.
Best for: Corporate communications, disease awareness campaigns, and microsites that do not carry promotional or drug-specific regulatory content. Not appropriate for product-level content, HCP portals, or multi-market regulated properties.
Sitecore: Personalization-Led Engagement
Strengths: Sitecore's CDP and Personalize engine are the most capable audience intelligence and personalization tools in this comparison. For HCP engagement programs where content must adapt to specialty, prescribing behavior, and market approval status, Sitecore's data infrastructure enables personalization at a scale other platforms cannot match. XM Cloud's SaaS model removes infrastructure management burden.
Weaknesses: Sitecore's strength in personalization is only valuable if you have a personalization strategy and the data to support it. Organizations without a clear HCP data program are paying for capabilities they will not use. The composable product family — multiple products, multiple contracts, multiple integrations — adds operational complexity.
Best for: Pharma organizations with omnichannel HCP engagement programs, existing CRM or field force data they want to activate in digital experiences, and a clear personalization strategy. Less compelling as a pure CMS for organizations whose primary need is content governance.
No CMS: Custom Development
Strengths: Zero licensing cost, maximum performance for static content, no vendor dependency, complete control over the data model and technology stack.
Weaknesses: Every content change requires a developer. MLR workflow, audit trails, localization infrastructure, and editorial interfaces must all be custom-built and maintained — turning a website project into a platform engineering project. For any pharmaceutical content that will be updated by non-developers or must demonstrate regulatory compliance, the total cost of building these capabilities from scratch consistently exceeds the cost of a purpose-built platform.
Best for: Truly static microsites with no editorial updates planned, developer-facing API documentation, internal tools with a single technical maintainer, and proof-of-concept work before committing to a full platform.
Not appropriate for: Any property carrying promotional or regulatory pharmaceutical content, multi-market deployments, HCP portals, patient support programs, or properties requiring documented MLR approval processes.
How to Choose
Answer these questions before shortlisting platforms:
How many markets do you manage? Under five markets, almost any platform works. Above ten, multi-site management capability becomes critical — Magnolia, AEM, and Sitecore are the strongest options.
What is your MLR workflow complexity? Simple two-stage approval: Drupal or WordPress with appropriate tooling. Complex multi-stage MLR with external reviewers and audit requirements: Magnolia Campus+, AEM, or Sitecore.
Do you have a personalization strategy? If yes, Sitecore or AEM with Adobe Target. If not yet, invest in strategy before investing in the platform that enables it.
What is your internal technical capacity? Low internal capacity: favor platforms with managed services and pre-built pharma features (Magnolia Campus+). High internal capacity: Drupal gives you the most flexibility at lowest licensing cost.
What is your existing technology stack? Already on Adobe: AEM is the natural anchor. Already on Microsoft/Azure: Sitecore or AEM both integrate well. No strong existing stack: Magnolia or Drupal offer the most vendor-neutral paths.
We help pharmaceutical organizations navigate CMS evaluations and implement the platform that best matches their actual requirements. If you are starting a CMS evaluation for a pharmaceutical digital property, explore our CMS Development service or contact our team to begin the conversation.